( April 8, 2025, 11:20 AM EDT) -- Mylan Inc. on April 7 agreed to pay up to $335 million in a multistate settlement agreement to end claims that the pharmaceutical company contributed to the opioid epidemic by manufacturing and selling various opioid products since 2005, including generic fentanyl patches, oxycodone, hydrocodone and buprenorphine products....